Maternal RSV Vaccine Cuts Infant Hospitalizations Nearly 70%
Real-world data published in JAMA Network Open confirm the effectiveness of the RSVpreF vaccine in protecting newborns from respiratory syncytial virus.
Real-world data published in JAMA Network Open confirm the effectiveness of the RSVpreF vaccine in protecting newborns from respiratory syncytial virus.
Real-world data published in JAMA Network Open confirm the effectiveness of the RSVpreF vaccine in protecting newborns from respiratory syncytial virus.
Read MoreThe families of two infants who died in the 1960s are suing the federal government alleging the babies received an experimental RSV vaccine without the knowledge or consent of their families, according to a report by The New York Times.
Read MoreMaternal RSV vaccination reduced infants’ hospitalization risk by more than 80% when administered at least 14 days before birth.
Read MoreAn NFID initiative provided evidence-based guidance on influenza, COVID-19, and RSV during the 2025-2026 season.
Read MoreA US district court blocked HHS Secretary Robert Kennedy Jr’s recent moves to revise the federal childhood vaccine schedule and overhaul of the CDC’s vaccine advisory board, according to multiple media reports including Reuters.
Read MoreThe American College of Physicians recommends an RSV vaccine for all adults age 75 and older.
Read MoreThe 2026 AAP recommendations remain largely unchanged from 2025 but differ from the CDC’s new immunization schedule.
Read MoreAAP president Andrew D. Racine is raising alarms over the federal government’s removal of several vaccinations from its Childhood Immunization Schedule.
Read MoreThe CDC and HHS reduced the federally recommended childhood immunization schedule from 17 to 11 vaccinations, removing shots for seasonal flu and other infectious diseases.
Read MoreFor RSV awareness month (October), the American Lung Association is spotlighting new data that show a dramatic decrease in RSV-related hospitalizations among infants.
Read MoreOne shot of an RSV vaccine protects adults ages 60 or older from RSV-associated hospitalization and critical illness during two consecutive RSV seasons.
Read MoreCDC’s annual respiratory disease season outlook predicts similar peak hospitalization rates for COVID-19, influenza and RSV — but a higher hospitalization rate for COVID-19 if a new variant emerges.
Read MoreThe American Academy of Pediatrics published its pediatric immunization recommendations for influenza, RSV, and COVID-19, which differ from some recommendations made by the FDA.
Read MoreA new ESC Clinical Consensus Statement reports on the beneficial effects of vaccines in reducing cardiovascular events following various viral and bacterial infections, particularly in at-risk patient groups.
Read MoreUS Department of Health and Human Services Secretary Robert F. Kennedy has removed all 17 members of the CDC’s Advisory Committee for Immunization Practices (ACIP), according to multiple media reports.
Read MoreThe World Health Organization issued its first-ever recommendations for immunizing infants against RSV, which is the leading cause of acute lower respiratory infections in children globally.
Read MoreA recent CDC statement may signal a shift in the agency’s longstanding practice of advocating vaccinations for infectious diseases like measles.
Read MoreScientist offer strategies to address anti-vaccine sentiment in the US, including actively countering health disinformation.
Read MoreAn RSV vaccine program targeted at seniors in Scotland found 68% of adults aged 75-79 were vaccinated which led to a 62% reduction in RSV-related hospitalizations.
Read MoreThe FDA has required Guillain-Barré syndrome warnings to be added to prescribing information for RSV vaccines Abrysvo and Arexvy.
Read MoreA new Annenberg Public Policy Center survey reveals evolving public attitudes toward vaccines—including RSV, flu, COVID-19, and MMR—in the United States.
Read MoreInequalities in childhood vaccination are widening in England, with uptake rates of five key vaccines consistently lower in young children living in areas of higher deprivation from 2019 to 2023.
Read MoreEpidemiologist Annette Regan explains why officials recommend that people get these shots over the coming months.
Read MoreA survey found that 44% of Americans are likely to get a yearly COVID-19 vaccine if recommended by the CDC, a drop from 52% just eight months earlier.
Read More